IL HB2438

Requires Illinois Medical Assistance program to cover routine care costs incurred during approved clinical trials if the same costs would be covered outside a clinical trial.

Defines "approved clinical trial" as phase I, II, III, or IV trials for prevention, detection, or treatment of cancer or other life-threatening diseases, meeting one of four criteria including FDA approval, Department determination, or funding/approval by specified federal agencies and entities.

Defines "routine care costs" as medically necessary services related to the care method under evaluation, including treatment of complications from the trial, but excluding the investigational drug or device itself and data collection services.

Coverage remains subject to all existing Medical Assistance program terms, conditions, restrictions, exclusions, and limitations that apply to participating and nonparticipating providers.